Tonix Pharmaceuticals Holding (TNXP) Earnings Date & Reports

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

TNXP is expected to report earnings to -246 cents per share on November 09

Tonix Pharmaceuticals Holding TNXP Stock Earnings Reports

Q3'26

Est.

$-2.46

Q2'26

Beat

by $0.27

Q1'26

Missed

by $0.35

Q4'25

Missed

by $0.79

Q3'25

Est.

$-3.59

The last earnings report on August 10 showed earnings per share of -244 cents, beating the estimate of -271 cents. With 520.35K shares outstanding, the current market capitalization sits at 213.36M.

View a ticker or compare two or three

TNXP

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days